Corteva AI Stock Analysis
Want to see CTVA full AI Analyst Report?
Corteva (CTVA) AI Stock Analysis
Corteva
(NYSE:CTVA)
CTVA scores as a mid-range setup: financials show improving margins and low leverage, but the recent TTM cash flow reversal is the biggest fundamental risk. Technically, the stock is in a pronounced downtrend (below all major DMAs with negative MACD), though it is deeply oversold (low RSI). Valuation is a notable offset with a low P/E and a modest dividend, while the latest earnings call was tempered by reduced EBITDA guidance and Brazil/channel-inventory headwinds.
Corteva Key Performance Indicators (KPIs)
Seed Sales by SegmentTracks revenue from seed sales across various segments, indicating market demand and competitive positioning in the agriculture sector.
Corn is the clear growth engine—seasonal planting spikes are recurring, and Q1 2026 shows an outsized corn uplift that matches management’s reported seed volume and price/mix strength plus royalty improvement. That Q1 gain likely includes timing (early planting) so some pullback into later quarters is possible, but licensing momentum in Brazil and productivity tailwinds support the company’s guidance; monitor acreage mix shifts and energy/input cost risks that could temper sustained upside.
Corteva (CTVA) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.29B
- Dividend Yield
- 1.15%
- Average Volume (3M)
- 18.83M
- Price to Earnings (P/E)
- 7.8
- Beta (1Y)
- 0.36
- Revenue Growth
- 1.05%
- EPS Growth
- -51.65%
- Country
- US
- Employees
- 21,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
Corteva Business Overview & Revenue Model
Company Description
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait techno...
How the Company Makes Money
Corteva makes money primarily by selling agricultural inputs to farmers and distributors, with revenue concentrated in two main streams: (1) Seed and (2) Crop Protection. In Seed, Corteva generates sales from proprietary seed products (notably corn a...
Corteva Earnings Call Summary
The call presented strong execution, innovation, productivity and growth across North America, EMEA and Asia Pacific, supported by new product growth and expanded year-to-date margins. However, the significant deterioration in Brazil, elevated channel inventory, pricing pressure, lower full-year EBITDA guidance and an expected fourth-quarter EBITDA decline were central to the discussion. The negative Brazil-driven outlook outweighed the otherwise solid performance in the rest of the business.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Corteva updated 2026 stand-alone operating EBITDA guidance to a range of $1.1 billion to $1.125 billion, with full year operating EBITDA expected to be down 12% versus last year at the midpoint and operating EBITDA margin of about 15%; fourth quarter EBITDA is expected to be about half of 2025 levels on an adjusted pro forma basis, operating EPS is expected to be in the range of $0.76 to $0.80 per share, up about 3% at the midpoint, and the full year EBITDA impact related to elevated channel inventory is estimated at approximately $100 million. Fourth quarter revenue is expected to be around $2 billion, down year-over-year, with volumes generally flat year-over-year and pricing down high single digits; U.S. acetochlor is expected to contribute a fourth-quarter headwind closer to that $40-ish million level, with a little bit of it in the first quarter and no year-over-year headwinds expected by the second quarter of 2027. Corteva remains on track for a year-end cash position of about $1.5 billion, around $1 billion of financial debt, underlying fourth-quarter CapEx of about $50 million, and expects to grow the business in 2027.
Corteva Financial Statement Overview
Summary
Operating fundamentals are mixed: revenue has been broadly flat with improved gross margin and operating profitability, and the balance sheet is conservatively levered. The main drag is TTM cash conversion—very low operating cash flow and negative free cash flow despite positive earnings—raising near-term quality-of-earnings and flexibility concerns alongside a jump in total debt in TTM.
Income Statement
64PositiveBalance Sheet
78PositiveCash Flow
42Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.65B | 17.40B | 16.91B | 17.23B | 17.45B | 15.65B |
| Gross Profit | 8.58B | 8.23B | 7.38B | 7.31B | 7.02B | 6.43B |
| EBITDA | 3.06B | 3.07B | 2.73B | 2.54B | 2.73B | 3.62B |
| Net Income | 759.00M | 1.09B | 907.00M | 735.00M | 1.15B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 43.03B | 42.84B | 40.83B | 43.00B | 42.62B | 42.34B |
| Cash, Cash Equivalents and Short-Term Investments | 3.93B | 4.53B | 3.17B | 2.74B | 3.31B | 4.54B |
| Total Debt | 7.45B | 2.58B | 2.70B | 2.49B | 1.31B | 1.12B |
| Total Liabilities | 18.29B | 18.46B | 16.80B | 17.72B | 17.08B | 16.72B |
| Stockholders Equity | 24.49B | 24.14B | 23.79B | 25.04B | 25.30B | 25.38B |
Cash Flow | ||||||
| Free Cash Flow | -149.00M | 2.81B | 1.55B | 1.17B | 267.00M | 2.15B |
| Operating Cash Flow | 427.00M | 3.41B | 2.15B | 1.77B | 872.00M | 2.73B |
| Investing Cash Flow | -578.00M | -543.00M | -589.00M | -1.99B | -632.00M | -362.00M |
| Financing Cash Flow | 1.79B | -1.64B | -1.20B | -99.00M | -1.18B | -1.27B |
Corteva Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTVA, the sentiment is Negative. The current price of 9.43 is below the 20-day moving average (MA) of 11.83, below the 50-day MA of 12.30, and below the 200-day MA of 12.09, indicating a bearish trend. The MACD of -0.52 indicates Positive momentum. The RSI at 27.39 is Positive, neither overbought nor oversold. The STOCH value of 23.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CTVA.
Corteva Risk Analysis
Corteva disclosed 31 risk factors in its most recent earnings report. Corteva reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksCorteva Peers Comparison
Overall Rating
CF77Outperform
CTVA59Neutral
ICL55Neutral
MOS47Neutral
FMC42Neutral
BIOX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $18.30B | 8.80 | 40.30% | 1.76% | 17.87% | 70.91% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 59Neutral | $6.29B | 7.79 | 3.09% | 1.15% | 1.05% | -51.65% | |
| 55Neutral | $5.83B | 18.64 | 5.09% | 4.56% | 10.15% | -15.98% | |
| 47Neutral | $6.97B | -16.48 | -3.78% | 4.01% | 0.02% | -191.20% | |
| 42Neutral | $810.46M | -0.16 | -308.88% | 6.14% | -21.99% | -677.23% | |
| 38Underperform | $13.40M | -0.06 | -216.09% | ― | -26.10% | 14.85% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CTVA | Corteva | 9.43 | -0.06 | -0.67% | |
| CF | Cf Industries Holdings, Inc. | 125.09 | 45.56 | 57.30% | |
| FMC | FMC Corp | 5.21 | -7.40 | -58.69% | |
| MOS | Mosaic Co | 21.92 | -1.73 | -7.32% | |
| ICL | Icl Group Ltd. | 4.52 | -0.70 | -13.39% | |
| BIOX | Bioceres Crop Solutions | 0.21 | -1.33 | -86.41% |
Corteva Corporate Events
Corteva separation faces legal challenge and appellate review
NegativeOn October 1, 2026, Corteva, Inc. completed its separation from Vylor Inc. into two independent, publicly traded companies, a transaction that was immediately challenged by litigation brought by 15 states and one sovereign in the U.S. District Court...
Corteva Subsidiary Streamlines Debt Through Note Exchange
PositiveOn October 1, 2026, Vylor Inc. completed private exchange offers for multiple series of outstanding senior notes issued by Corteva’s subsidiary EIDP, Inc., swapping them for new Vylor notes held by eligible investors and conducting related consent so...
Corteva completes spin-off of seed business into Vylor
PositiveAt 12:03 a.m. New York City time on October 1, 2026, Corteva completed the previously announced spin-off of its seed operating segment into Vylor Inc., which became an independent, publicly traded company listed on the New York Stock Exchange under t...
Corteva completes spin-off of seed business Vylor
PositiveOn October 1, 2026, Corteva completed the previously announced separation of its seed operating segment into a standalone, publicly traded company, Vylor Inc., via a pro rata distribution of Vylor shares to Corteva shareholders of record as of Septem...
Corteva Realigns Debt Structure Ahead Planned Separation
PositiveOn October 1, 2026, Corteva announced that its wholly owned subsidiary Vylor Inc. had completed private exchange offers and related consent solicitations for three series of EIDP, Inc. senior notes, which expired on September 30, 2026. Participation...
Corteva completes Vylor seed business spin-off despite challenge
PositiveOn September 30, 2026, the U.S. Court of Appeals for the Fourth Circuit reversed a District Court order that had blocked California from seeking to delay Corteva’s planned separation of its seed business into Vylor Inc., remanding the case without ru...
Corteva extends debt exchange ahead planned business separation
PositiveOn September 30, 2026, Corteva’s subsidiary Vylor Inc. extended by one day, to 5:00 p.m. New York City time on September 30, 2026, the expiration date for its private exchange offers and related consent solicitations involving EIDP, Inc.’s 2.300% 203...
Corteva Announces Spin-Off and NYSE Listing of Vylor
PositiveOn September 24, 2026, Corteva announced that the U.S. Securities and Exchange Commission had declared effective Vylor’s Form 10 registration statement, detailing the planned separation of Vylor into an independent, publicly traded company. The move...
Corteva’s EIDP Registers Notes, Advancing Separation Plan
PositiveIn connection with its planned separation into two publicly traded companies announced on October 1, 2025, Corteva’s affiliate EIDP, Inc. privately issued $700 million of 6.000% senior notes due August 15, 2036, with semiannual interest payments begi...
Corteva Advances Vylor Seed Business Spin-Off Plans
PositiveOn September 21, 2026, Corteva subsidiary Vylor, Inc. filed Amendment No. 3 to its Form 10 registration statement with the U.S. Securities and Exchange Commission, advancing Corteva’s previously announced plan to separate its seed operating segment i...
Corteva Advances Vylor Spin-Off and Investor Day Plans
PositiveOn September 12, 2026, Corteva’s board of directors approved the previously announced plan to separate its seed operating segment into Vylor, Inc., creating two independent, publicly traded agriculture companies. The spin-off will be executed via a p...
Corteva, DuPont, Chemours Settle North Carolina PFAS Claims
PositiveOn September 9, 2026, Corteva, DuPont and Chemours reached a comprehensive settlement with the State of North Carolina and several local governments to resolve statewide PFAS claims and Fayetteville Works site related claims, including all historical...
Corteva Advances Seed Business Spin-Off Via Vylor Notes
PositiveOn October 1, 2025, Corteva’s board approved a plan to separate the company into two listed businesses, one for crop protection and one for seeds, with the seed business to be owned and operated by Vylor Inc. In preparation for this separation, Vylor...
Corteva Advances Separation with Key Debt Indenture Changes
NeutralIn August 2026, Corteva advanced its planned separation into two publicly traded companies, one for crop protection and one for seeds, by having Vylor Inc. launch private exchange offers for several series of senior notes issued by subsidiary EIDP, I...
Corteva advances note exchange ahead planned business separation
PositiveOn August 20, 2026, Corteva announced that its subsidiary Vylor Inc. had secured the required majority consents from holders of EIDP, Inc. senior notes due 2030, 2032 and 2033 for private exchange offers and related indenture amendments, with early t...
Corteva Advances Vylor Spin-Off With Amended Filing
PositiveOn August 14, 2026, Vylor, Inc., a subsidiary of Corteva, filed the first amendment to its Form 10 registration statement with the U.S. Securities and Exchange Commission, detailing Vylor’s business, strategy and historical financial results. The fil...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026
